RVL Pharmaceuticals (NASDAQ:RVLP – Get Rating) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, March 30th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link. RVL Pharmaceuticals stock […]
TFF Pharmaceuticals (NASDAQ:TFFP – Get Rating) announced its earnings results on Thursday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.12), MarketWatch Earnings reports. TFF Pharmaceuticals had a negative net margin of 35,272.73% and a negative return on equity of 57.16%. During the same period […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) Director Patrick D. Walsh bought 5,000 shares of the business’s stock in a transaction dated Monday, March 21st. The shares were bought at an average cost of $27.76 per share, for a total transaction of $138,800.00. The acquisition was disclosed in a legal filing with the SEC, which […]
ORIC Pharmaceuticals (NASDAQ:ORIC – Get Rating) posted its quarterly earnings results on Monday. The company reported ($0.58) EPS for the quarter, hitting analysts’ consensus estimates of ($0.58), MarketWatch Earnings reports. During the same quarter in the prior year, the firm posted ($0.84) earnings per share. Shares of ORIC stock opened at $4.76 on Wednesday. ORIC […]
Zacks Investment Research upgraded shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday morning, Zacks.com reports. The firm currently has $3.00 target price on the biopharmaceutical company’s stock. According to Zacks, “TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company’s product candidate […]